The effective management of urological malignancies

The epidemiology of prostate cancer - rates and risk factors; Genetic predisposition and environmental influences on the genesis of prostate cancer; The rationale for active surveillance of early prostate cancer; Early prostate cancer - the evidence base for surgical intervention; External beam radiotherapy and neoadjuvant hormone therapy for prostate cancer; Evidence and opinion for endocrine manipulation in prostate cancer; Evidence and opinion for radiotherapy in advanced prostate cancer; Evidence and opinion for chemotherapy in advanced prostate cancer; Prostate brachytherapy; Cellular immunotherapy for prostate cancer; Clonal development of bladder cancer - insights from genetic studies; Evidence and opinion for the use of intravesical chemotherapy and BCG immunotherapy in superficial bladder cancer; Photodynamic diagnosis in superficial bladder cancer; Chemotherapy in metastatic urothelial cancer; The effects of tumour factors, patient factors and treatment delay on the prognosis of bladder cancer; The diagnosis of testicular tumours and the two-week rule; Evidence and opinion for the management of stage I testicular germ-cell tumours; Current research questions in testicular cancer; Diagnosis and management of penile pre-cancer - combined clinics and topical chemotherapy; Modern management of penile cancer; Chemoradiotherapy for penile cancer